AstraZeneca, Oxford Biomedica expand COVID-19 vaccine supply tie-up

By: |
September 1, 2020 1:45 PM

AstraZeneca has expanded its previous agreement with Oxford Biomedica to mass-produce the British drugmaker's COVID-19 vaccine candidate, as it looks to scale-up supply ahead of a possible fast-track approval from the United States.

Coronavirus vaccine latest updates: AstraZeneca-Oxford COVID-19 vaccine, covid19 medication, coronavirus drug, who, moderna, russian vaccine, indian covid 19 vaccine, sinovac biotech, pfizer, remdesivir, coviforAstraZeneca would give it 15 million pounds ($20 million) upfront to reserve manufacturing capacity at its plant.

AstraZeneca has expanded its previous agreement with Oxford Biomedica to mass-produce the British drugmaker’s COVID-19 vaccine candidate, as it looks to scale-up supply ahead of a possible fast-track approval from the United States.

Gene and cell therapy firm Oxford Biomedica said on Tuesday AstraZeneca would give it 15 million pounds ($20 million) upfront to reserve manufacturing capacity at its plant and that it could get an additional 35 million pounds plus other costs until the end of 2021 under the new 18-month deal.

AstraZeneca’s vaccine hopeful for the novel coronavirus, AZD1222, already among the leading candidates in the global race for a successful vaccine, moved to late stage trials in the United States this week as the company targets 3 billion doses of the vaccine.

Oxford Biomedica was among AstraZeneca’s initial partners when they teamed up in May to produce the vaccine and Tuesday’s deal could be further expanded by another year and a half into 2022 and 2023, Oxford said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1WHO urges actions for ‘long COVID’ sufferers
2Active cases in India at 1,51,708, over 89 per cent of new cases from seven states
3Maharashtra: 229 school hostel students test coronavirus positive